市场调查报告书
商品编码
1287283
精子计数测试市场规模 - 按技术(显微镜、色谱免疫分析和量热反应、基于智能手机)、按年龄组(34岁及以下、34岁、35-40岁、41岁及以上)、按最终用途及预测,2023 - 2032年Sperm Count Test Market Size - By Technique (Microscopy, Chromatographic Immunoassay & Calorimetric Reaction, Smartphone-based), By Age Group (34 & Below, 34 Years, 35-40 Years, 41 Years & Above), By End-use & Forecast, 2023 - 2032 |
全球精子计数测试市场规模将在2032年之前积累大量收益。一些经济体的快速工业化导致医院和其他治疗设施的建设,并配备了先进的精子计数测试工具,对行业格局产生了积极影响。此外,行业的增长也可以归功于全球蓬勃发展的医疗设备部门。举例来说,根据IBEF的数据,到2025年,印度的医疗设备行业有可能达到500亿美元。
整个精子数量测试市场根据技术、年龄组、终端用途和地区划分。
色谱免疫测定和量热反应部分的精子计数测试市场将在2032年之前显著扩大。色谱免疫测定法和量热反应法在精子数量测试中都有很高的准确性和精确度,这有利于它们的采用。这些方法甚至可以检测出精子浓度、活力和存活率的微小变化,使医疗保健提供者能够对病人的最佳治疗方案做出更明智的决定。
就年龄段而言,从2023年到2032年,34岁年龄段的精子计数测试市场份额将以有利可图的复合年增长率增长。这个年龄段的男性不孕不育症的发病率越来越高,增加了对精子数量测试的需求。此外,这一人群也很容易因过度饮酒和吸烟而出现生活方式紊乱,从而影响到他们的生育能力。该部分的增长也可归因于这个年龄段的人对生殖健康的认识不断提高。
根据最终用途,医院和诊所部分的市场价值将在2032年之前明显增长。医院和诊所有大量具有成本效益的诊断解决方案,增加了这些设施的病人数量。此外,政府对建设新医院和诊所的投资激增,将促进该领域的增长。2022年10月,美国政府公布了一项超过1.1亿美元的投资,以改善农村人口的医疗保健。这项投资将有助于在农村地区建立医院和诊所。
欧洲精子数量测试行业将在2023-2032年期间见证可观的增长。该地区男性不孕不育率的增长,增加了对精子数量测试的需求。区域扩张也可归因于完善的医疗基础设施和日益增长的生殖健康意识。欧洲也有一个强大的市场领导者,如Vitrolife AB,和其他不断从事产品创新的公司。这也将有利于估计期内的市场动态。
Global Sperm Count Test Market size will amass substantial gains through 2032. Rapid industrialization across several economies has led to the construction of hospitals and other treatment facilities with advanced sperm count test kits, positively impacting the industry landscape. Moreover, industry growth can also be ascribed to the flourishing medical device sector globally. To illustrate, according to IBEF, the medical device industry in India has the potential to hit USD 50 billion by 2025.
The overall sperm count test market is divided based on technique, age group, end-use, and region.
Sperm count test market from the chromatographic immunoassay & calorimetric reaction segment will expand significantly through 2032. Both chromatographic immunoassay and calorimetric reaction offer high levels of accuracy and precision in sperm count testing, which favors their adoption. These methods can detect even small variations in sperm concentration, motility, and viability, enabling healthcare providers to make more informed decisions about the best course of treatment for their patients.
In terms of age group, sperm count test market share from the 34 years segment will grow at a lucrative CAGR from 2023 to 2032. Growing prevalence of infertility in males of this age has increased the need for sperm count tests. Moreover, this demographic is also susceptible to lifestyle disorders due to excessive alcohol intake and smoking, which affects their fertility. Segment growth can also be attributed to growing awareness about reproductive health among people of this age group.
Based on end use, the market value from the hospitals & clinics segment will grow notably through 2032. High availability of cost-effective diagnostic solutions in hospitals & clinics has increased patient footfall in these facilities. Moreover, surging government investments in building new hospitals & clinics will contribute to segment growth. In October 2022, the U.S. government unveiled an investment of more than USD 110 million to improve healthcare for rural people. This investment will help build hospitals & clinics in rural locations.
Europe sperm count test industry will witness appreciable growth during 2023-2032. Growing incidence of male infertility rates in the region has increased the demand for sperm count tests. Regional expansion can also be attributed to well-established healthcare infrastructure and the growing awareness about reproductive health. Europe also has a robust presence of market leaders such as Vitrolife AB, and others constantly engaged in product innovations. This will also favor the market dynamics over the estimation period.